Robin Jones to Electrocardiography
This is a "connection" page, showing publications Robin Jones has written about Electrocardiography.
Connection Strength
0.179
-
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer. Cancer Chemother Pharmacol. 2015 Oct; 76(4):777-84.
Score: 0.121
-
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity. Lancet Oncol. 2005 Feb; 6(2):67.
Score: 0.058